Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis-A Randomized Placebo Controlled Clinical Trial

Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis-A Randomized Placebo Controlled Clinical Trial

In December 2019 the SARS-CoV-2 virus appeared in the world, mainly presenting as an acute infection of the lower respiratory tract, namely pneumonia. Nearly 10% of all patients show significant pulmonary fibrotic changes after the infection. The aim of this study was to evaluate the effectiveness a...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarzyna Kotfis (Author), Igor Karolak (Author), Kacper Lechowicz (Author), Małgorzata Zegan-Barańska (Author), Agnieszka Pikulska (Author), Paulina Niedźwiedzka-Rystwej (Author), Miłosz Kawa (Author), Jerzy Sieńko (Author), Aleksandra Szylińska (Author), Magda Wiśniewska (Author)
Format: Book
Published: MDPI AG, 2022-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items